Literature DB >> 21460838

Ephrin Bs are essential components of the Reelin pathway to regulate neuronal migration.

Aycan Sentürk1, Sylvia Pfennig, Alexander Weiss, Katja Burk, Amparo Acker-Palmer.   

Abstract

Coordinated migration of neurons in the developing and adult brain is essential for its proper function. The secreted glycoprotein Reelin (also known as RELN) guides migration of neurons by binding to two lipoprotein receptors, the very-low-density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoER2, also known as LRP8). Loss of Reelin function in humans results in the severe developmental disorder lissencephaly and it has also been associated with other neurological disorders such as epilepsy, schizophrenia and Alzheimer's disease. The molecular mechanisms by which Reelin activates its receptors and controls cellular functions are largely unknown. Here we show that the neuronal guidance cues ephrin B proteins are essential for Reelin signalling during the development of laminated structures in the brain. We show that ephrin Bs genetically interact with Reelin. Notably, compound mouse mutants (Reln(+/-); Efnb3(-/-) or Reln(+/-); Efnb2(-/-)) and triple ephrin B1, B2, B3 knockouts show neuronal migration defects that recapitulate the ones observed in the neocortex, hippocampus and cerebellum of the reeler mouse. Mechanistically, we show that Reelin binds to the extracellular domain of ephrin Bs, which associate at the membrane with VLDLR and ApoER2 in neurons. Clustering of ephrin Bs leads to the recruitment and phosphorylation of Dab1 which is necessary for Reelin signalling. Conversely, loss of function of ephrin Bs severely impairs Reelin-induced Dab1 phosphorylation. Importantly, activation of ephrin Bs can rescue the reeler neuronal migration defects in the absence of Reelin protein. Together, our results identify ephrin Bs as essential components of the Reelin receptor/signalling pathway to control neuronal migration during the development of the nervous system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21460838     DOI: 10.1038/nature09874

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  34 in total

1.  Reelin, Disabled 1, and beta 1 integrins are required for the formation of the radial glial scaffold in the hippocampus.

Authors:  Eckart Förster; Albrecht Tielsch; Barbara Saum; Karl Heinz Weiss; Celine Johanssen; Diana Graus-Porta; Ulrich Müller; Michael Frotscher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

2.  Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex.

Authors:  Olga Britanova; Camino de Juan Romero; Amanda Cheung; Kenneth Y Kwan; Manuela Schwark; Andrea Gyorgy; Tanja Vogel; Sergey Akopov; Miso Mitkovski; Denes Agoston; Nenad Sestan; Zoltán Molnár; Victor Tarabykin
Journal:  Neuron       Date:  2008-02-07       Impact factor: 17.173

Review 3.  Reelin, lipoprotein receptors and synaptic plasticity.

Authors:  Joachim Herz; Ying Chen
Journal:  Nat Rev Neurosci       Date:  2006-11       Impact factor: 34.870

4.  Reelin expression and glycosylation patterns are altered in Alzheimer's disease.

Authors:  Arancha Botella-López; Ferran Burgaya; Rosalina Gavín; M Salud García-Ayllón; Estrella Gómez-Tortosa; Jordi Peña-Casanova; Jesús M Ureña; José A Del Río; Rafael Blesa; Eduardo Soriano; Javier Sáez-Valero
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

5.  Ephrin-B3 is the midline barrier that prevents corticospinal tract axons from recrossing, allowing for unilateral motor control.

Authors:  K Kullander; S D Croll; M Zimmer; L Pan; J McClain; V Hughes; S Zabski; T M DeChiara; R Klein; G D Yancopoulos; N W Gale
Journal:  Genes Dev       Date:  2001-04-01       Impact factor: 11.361

6.  Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations.

Authors:  S E Hong; Y Y Shugart; D T Huang; S A Shahwan; P E Grant; J O Hourihane; N D Martin; C A Walsh
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

7.  Transgenic mouse proteomics identifies new 14-3-3-associated proteins involved in cytoskeletal rearrangements and cell signaling.

Authors:  Pierre-Olivier Angrand; Inmaculada Segura; Pamela Völkel; Sonja Ghidelli; Rebecca Terry; Miro Brajenovic; Kristina Vintersten; Rüdiger Klein; Giulio Superti-Furga; Gerard Drewes; Bernhard Kuster; Tewis Bouwmeester; Amparo Acker-Palmer
Journal:  Mol Cell Proteomics       Date:  2006-09-06       Impact factor: 5.911

8.  A novel method of labeling and characterizing migrating neurons in the developing central nervous system.

Authors:  Pavlos Alifragis; John G Parnavelas; Bagirathy Nadarajah
Journal:  Exp Neurol       Date:  2002-04       Impact factor: 5.330

9.  Abnormal reorganization of preplate neurons and their associated extracellular matrix: an early manifestation of altered neocortical development in the reeler mutant mouse.

Authors:  A M Sheppard; A L Pearlman
Journal:  J Comp Neurol       Date:  1997-02-10       Impact factor: 3.215

10.  Reelin activates SRC family tyrosine kinases in neurons.

Authors:  Hans H Bock; Joachim Herz
Journal:  Curr Biol       Date:  2003-01-08       Impact factor: 10.834

View more
  75 in total

Review 1.  'Til Eph do us part': intercellular signaling via Eph receptors and ephrin ligands guides cerebral cortical development from birth through maturation.

Authors:  Hilary A North; Meredith A Clifford; Maria J Donoghue
Journal:  Cereb Cortex       Date:  2012-06-28       Impact factor: 5.357

Review 2.  Mechanisms of ephrin-Eph signalling in development, physiology and disease.

Authors:  Artur Kania; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-21       Impact factor: 94.444

Review 3.  Integrative mechanisms of oriented neuronal migration in the developing brain.

Authors:  Irina Evsyukova; Charlotte Plestant; E S Anton
Journal:  Annu Rev Cell Dev Biol       Date:  2013-08-07       Impact factor: 13.827

Review 4.  Eph receptor signaling and ephrins.

Authors:  Erika M Lisabeth; Giulia Falivelli; Elena B Pasquale
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

5.  Spatial and morphological reorganization of endosymbiosis during metamorphosis accommodates adult metabolic requirements in a weevil.

Authors:  Justin Maire; Nicolas Parisot; Mariana Galvao Ferrarini; Agnès Vallier; Benjamin Gillet; Sandrine Hughes; Séverine Balmand; Carole Vincent-Monégat; Anna Zaidman-Rémy; Abdelaziz Heddi
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-28       Impact factor: 11.205

6.  Sentürk et al. reply.

Authors:  A Sentürk; S Pfennig; A Weiss; K Burk; A Acker-Palmer
Journal:  Nature       Date:  2016-11-24       Impact factor: 49.962

7.  Genome-wide Methyl-Seq analysis of blood-brain targets of glucocorticoid exposure.

Authors:  Fayaz Seifuddin; Gary Wand; Olivia Cox; Mehdi Pirooznia; Laura Moody; Xiaoju Yang; Jonathan Tai; Gretha Boersma; Kellie Tamashiro; Peter Zandi; Richard Lee
Journal:  Epigenetics       Date:  2017-05-30       Impact factor: 4.528

8.  α1ACT Is Essential for Survival and Early Cerebellar Programming in a Critical Neonatal Window.

Authors:  Xiaofei Du; Cenfu Wei; Daniel Parviz Hejazi Pastor; Eshaan R Rao; Yan Li; Giorgio Grasselli; Jack Godfrey; Ann C Palmenberg; Jorge Andrade; Christian Hansel; Christopher M Gomez
Journal:  Neuron       Date:  2019-03-25       Impact factor: 17.173

9.  EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma.

Authors:  Nicole McKinney; Liangping Yuan; Hongying Zhang; Jingbo Liu; Yoon-Jae Cho; Elisabeth Rushing; Matthew Schniederjan; Tobey J MacDonald
Journal:  J Neurooncol       Date:  2014-09-26       Impact factor: 4.130

10.  Reelin induces Erk1/2 signaling in cortical neurons through a non-canonical pathway.

Authors:  Gum Hwa Lee; Zinal Chhangawala; Sventja von Daake; Jeffrey N Savas; John R Yates; Davide Comoletti; Gabriella D'Arcangelo
Journal:  J Biol Chem       Date:  2014-05-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.